OTC Markets OTCQB - Delayed Quote USD

Izotropic Corporation (IZOZF)

Compare
0.1350
0.0000
(0.00%)
At close: January 17 at 3:00:00 PM EST

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Robert Louis Thast Founder, Interim CEO & Chairman -- -- 1954
Mr. Ralph F. Proceviat CPA CFO & Director -- -- 1950
Dr. Younes Achkire Ph.D. Executive VP of Product Engineering & COO -- -- --
Mr. Ali Reza Sodagar Legal Advisor & Independent Director -- 54.18k --
Ms. Jaclyn Thast Operations Manager & Corporate Secretary -- -- --

Izotropic Corporation

800-15355 24th Avenue
Suite 424
Surrey, BC V4A 2H9
Canada
833-496-2677 https://izocorp.com
Sector: 
Healthcare

Description

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

Corporate Governance

Izotropic Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 31, 2025 at 10:59 AM UTC - April 4, 2025 at 12:00 PM UTC

Izotropic Corporation Earnings Date

Recent Events

November 25, 2022 at 12:00 AM UTC

D: Additional Forms

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.